IL326602A - מאפנני פירידיל אמין שלישוניים לביוסינתיזה של כולסטרול ושימושים בהם לקידום רמילינציה - Google Patents

מאפנני פירידיל אמין שלישוניים לביוסינתיזה של כולסטרול ושימושים בהם לקידום רמילינציה

Info

Publication number
IL326602A
IL326602A IL326602A IL32660226A IL326602A IL 326602 A IL326602 A IL 326602A IL 326602 A IL326602 A IL 326602A IL 32660226 A IL32660226 A IL 32660226A IL 326602 A IL326602 A IL 326602A
Authority
IL
Israel
Prior art keywords
compound
pharmaceutically acceptable
solvate
acceptable salt
alkyl
Prior art date
Application number
IL326602A
Other languages
English (en)
Original Assignee
Genentech Inc
Convelo Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Convelo Therapeutics Inc filed Critical Genentech Inc
Publication of IL326602A publication Critical patent/IL326602A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL326602A 2023-08-28 2024-08-27 מאפנני פירידיל אמין שלישוניים לביוסינתיזה של כולסטרול ושימושים בהם לקידום רמילינציה IL326602A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363579221P 2023-08-28 2023-08-28
PCT/US2024/044067 WO2025049495A1 (en) 2023-08-28 2024-08-27 Tertiary pyridyl amine modulators of cholesterol biosynthesis and their use for promoting remylination

Publications (1)

Publication Number Publication Date
IL326602A true IL326602A (he) 2026-04-01

Family

ID=92800630

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326602A IL326602A (he) 2023-08-28 2024-08-27 מאפנני פירידיל אמין שלישוניים לביוסינתיזה של כולסטרול ושימושים בהם לקידום רמילינציה

Country Status (7)

Country Link
EP (1) EP4770996A1 (he)
KR (1) KR20260060355A (he)
CN (1) CN121752546A (he)
AU (1) AU2024334493A1 (he)
IL (1) IL326602A (he)
MX (1) MX2026002492A (he)
WO (1) WO2025049495A1 (he)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4326525A (en) 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US5364620A (en) 1983-12-22 1994-11-15 Elan Corporation, Plc Controlled absorption diltiazem formulation for once daily administration
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5001139A (en) 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
US4992445A (en) 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
US4902514A (en) 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
WO2021247916A1 (en) * 2020-06-03 2021-12-09 Yumanity Therapeutics, Inc. Azetidine and spiroazetidine compounds and uses thereof
WO2023107547A2 (en) * 2021-12-08 2023-06-15 Kineta, Inc. Azetidine and spiroazetidine compounds and uses thereof

Also Published As

Publication number Publication date
CN121752546A (zh) 2026-03-27
MX2026002492A (es) 2026-04-01
KR20260060355A (ko) 2026-05-04
EP4770996A1 (en) 2026-07-08
WO2025049495A1 (en) 2025-03-06
AU2024334493A1 (en) 2026-01-29

Similar Documents

Publication Publication Date Title
AU2021377211A9 (en) Apparatus for delivering enhanced stimulation waveforms
IL321027A (he) מאפננים של פעילות tnf-אלפא
EP4038450A4 (en) ELECTRO-OPTICAL ELEMENTS AND FORMATION METHOD
GB2588305B (en) Apparatus of shaking compensation and method of shaking compensation
EP4061349A4 (en) CORONAVIRUS TREATMENT METHODS
EP4203342A4 (en) FREQUENCY COMPENSATION METHOD AND FREQUENCY COMPENSATION APPARATUS
EP4332264A4 (en) NON-ORIENTED SILICON STEEL AND PRODUCTION PROCESS THEREOF
IL317543A (he) מודולטורים של קינאז ושיטות לשימוש בהם
EP4274463A4 (en) METHODS AND DEVICES FOR EXTRACOCHLEAR STIMULATION
CA3299242A1 (en) Tertiary pyridyl amine modulators of cholesterol biosynthesis and their use for promoting remylination
EP4045644A4 (en) COMPOSITIONS AND METHODS OF USING ALTERNATIVE SPLICING TO REGULATE GENE THERAPY SPECIFICITY
EP3886353A4 (en) RELAY DEVICE TIME SYNCHRONIZATION APPARATUS AND METHOD THEREOF
GB2623894B (en) Ophthalmic apparatus and method of alignment of ophthalmic apparatus
IL325591A (he) צורה גבישית של בקסדרוסטאט ושיטה להכנתו ושימוש בו
ZA202101308B (en) Method and apparatus of music education
IL319624A (he) מאפנני אזול לביוסינתיזה של כולסטרול והשימוש בהם לקידום יצירה מחדש של מיאלין
CA234388S (en) Non-audiovisual aid teaching apparatus
IL326072A (he) צורה גבישית של בזוקלסטיניב, שיטה להכנתה והשימוש בה
HK40131026A (en) Cd122 binding agents and method of using same
HK40091385A (en) Il10rb binding molecules and methods of use
CA3268986A1 (en) Azole modulators of cholesterol biosynthesis and their use for promoting remyelination
AU2021904173A0 (en) Inhibitors of TBK1 and/or IKKε
ZA202105132B (en) Teaching aid for teaching mathematics and applied mathematics
ZA202301824B (en) Application of bacillus velezensis
PL4163211T3 (pl) Sposób montażu zestawów wyrobów sanitarnych i związana z nim aparatura